A role for IL-17 in age-related macular degeneration

Nature Reviews Immunology

Volumn 13, Issue 9, 2013, Pages 701-

  Shin, Jae Il ^a   Bayry, Jagadeesh ^b,c,d  

^a Yonsei University College of Medicine   (South Korea)

^b INSERM   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; INTERLEUKIN 17; INTERLEUKIN 1BETA;

ANGIOGENESIS; CYTOKINE PRODUCTION; INFLAMMATION; LETTER; PRIORITY JOURNAL; RETINA INJURY; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION;

EID: 84883180338     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3459-c1     Document Type: Letter

References (6)

1. Ambati, J. et al. Immunology of age-related macular degeneration. Nature Rev. Immunol. 13, 438-451 (2013).
2. Gaffen, S. L. Structure and signalling in the IL-17 receptor family. Nature Rev. Immunol. 9, 556-567 (2009).
3. Liu, B. et al. Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. J. Transl. Med. 9, 111 (2011).
4. Hasegawa, E. et al. IL-23-independent induction of IL-17 from T cells and innate lymphoid cells promotes experimental intraocular neovascularization. J. Immunol. 190, 1778-1787 (2013).
5. Tuo, J. et al. Anti-inflammatory recombinant TSG-6 stabilizes the progression of focal retinal degeneration in a murine model. J. Neuroinflammation 9, 59 (2012).
6. Takahashi, H. et al. Interleukin-17 enhances bFGF-, HGF-and VEGF-induced growth of vascular endothelial cells. Immunol. Lett. 98, 189-193 (2005).